
With Donald Trump set for a second stint in the White House, it remains to be seen what this means for future policies related to women’s health, research and reproductive rights.
At the time of writing, the official election result hasn’t been called, but Donald Trump, has already declared his victory, having won more than the 270-seat threshold needed.
Speaking to supporters in Florida, Trump said the Republicans had been given an ‘unprecedented and powerful mandate’ with the party on track to take control of the Senate, Congress and the House of Representatives.
In the wake of his claims that he is a “protector” of women— “whether they like it or not”— what does a Trump comeback mean for women’s health and related policies?
Robert F Kennedy to work on “health and women’s health”.
As 47th President of the United States, Trump is expected to appoint former Independent presidential candidate Robert F Kennedy to work on “health and women’s health”.
This could include giving him control of the Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS).
At his penultimate campaign rally in Pittsburgh, Pennsylvania, Trump said that should he return to the White House, RFK could “do what he wants” with women’s healthcare, adding “he’s so into women’s health.”
While it’s as yet unclear where this leaves the country’s public health policy, the former environmental lawyer has previously attracted criticism for his anti-vaccine comments and medical experts have raised concerns about his potential influence on the administration.
Abortion and reproductive rights
After the Supreme Court overturned Roe v. Wade In 2022, 20 states banned or severely restricted access to abortion, an unfolding of events which Trump has previously described as “a beautiful thing to watch.”
With the issue of abortion rights on the ballot this time around, seven states voted to protect abortion rights, a similar measure in Florida just falling short of the 60% needed to pass.
During her election campaign, Vice President Kamala Harris argued that if re-elected, Trump would further restrict abortion rights, while some advocates, medics and politicians believe he will seek to impose a federal ban.
But Trump looked to tone down his stance on abortion this time around, saying that he would not push for a national ban and that it should be up to the individual states.
He did not, however, comment on whether he would sign a federal abortion ban into law if one passed through Congress, and as President he previously backed a bill that would ban abortions after 20 weeks.
Widening healthcare gaps
Studies suggest the restrictions on abortion have already had a detrimental impact on infant and maternal mortality rates, as well as access to healthcare more broadly.
A study published in JAMA Pediatrics in June found that after Texas passed Senate Bill 8 (SB8), which heavily restricted abortions in 2021, there was an unexpected increase in infant and newborn deaths. Birth defects—one of the main causes of infant deaths—also increased in Texas but not in other parts of the US.
A separate study at two Texas hospitals looked at health complications among pregnant patients who needed to deliver before 22 weeks for medical reasons, but were required by Texas law to continue the pregnancy.
Researchers found that these Texas patients faced much higher rates of health issues compared to patients in other states who were allowed to end the pregnancy right away for medical reasons.
Meanwhile, CBS News reported this week that the Dobbs decision has impacted women’s health beyond abortion access, widening gaps in obstetrics and gynecological care in several states.
In an essay in JAMA author Rita Rubin highlights how after the Supreme Court decision, fewer new graduates from US medical schools applied for residency programs in states that banned or severely restricted abortion. This trend, noted by analyses from the Association of American Medical Colleges (AAMC) Research and Action Institute, contrasts with higher application rates in states where abortion remains legal.
Affordable Care Act
Trump may also turn his attention to policies which were introduced during his first presidency, but had not yet come into force, such as partially repealing the Affordable Care Act (also known as Obamacare), according to some reports.
During his first term, he passed the American Health Care Act (ACHA), which would have repealed the individual and employer mandate, amended Medicaid eligibility, and weakened protections for patients with pre-existing conditions.
In September’ ABC News debate, Trump said he had “concepts of a plan” to replace the ACA but failed to provide any details.
Research on women’s health
Some Democrats warned that a Trump win could mean undoing some of the progress that has been made in women’s health research under President Biden, The Hill reported earlier this month.
Last year the Biden administration created the White House Initiative on Women’s Health Research to boost investment in research on conditions that primarily affect the female reproductive system and those that affect women differently, or more commonly, than men.
The U.S. The Department of Defense and the National Institutes of Health have already committed to investing a combined $700 million in women’s health research, but Rep. Robin Kelly (D-Ill) and others warned that a Trump win could mean “less access for women, less resources for women, less research for women.”
However, others remain hopeful with legislation such as the Endometriosis CARE Act and the Women and Lung Cancer Research and Preventive Services Act of 2024, both of which are yet to pass, having both Democratic and Republican co-sponsors.
Katie Schubert, CEO of the Society for Women’s Health Research told The Hill: “All policymakers should recognise the value of investing in women’s health research and that such research is imperative to improve health care outcomes for all.”
While the impact of this election outcome on the healthcare sector remains to be seen, let’s hope Schubert is right.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









